Unknown

Dataset Information

0

HPLC methods for purity evaluation of man-made single-stranded RNAs.


ABSTRACT: Synthetic RNA oligos exhibit purity decreasing as a function of length, because the efficiency of the total synthesis is the numerical product of the individual step efficiencies, typically below 98%. Analytical methods for RNAs up to the 60 nucleotides (nt) have been reported, but they fall short for purity evaluation of 100nt long, used as single guide RNA (sgRNA) in CRISPR technology, and promoted as pharmaceuticals. In an attempt to exploit a single HPLC method and obtain both identity as well as purity, ion-pair reversed-phase chromatography (IP-RP) at high temperature in the presence of an organic cosolvent is the current analytical strategy. Here we report that IP-RP is less suitable compared to the conventional ion-exchange (IEX) for analysis of 100nt RNAs. We demonstrate the relative stability of RNA in the denaturing/basic IEX mobile phase, lay out a protocol to determine the on-the-column stability of any RNA, and establish the applicability of this method for quality testing of sgRNA, tRNA, and mRNA. Unless well resolving HPLC methods are used for batch-to-batch evaluation of man-made RNAs, process development will remain shortsighted, and observed off-target effects in-vitro or in-vivo may be partially related to low purity and the presence of shorter sequences.

SUBMITTER: Kanavarioti A 

PROVIDER: S-EPMC6356003 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

HPLC methods for purity evaluation of man-made single-stranded RNAs.

Kanavarioti Anastassia A  

Scientific reports 20190131 1


Synthetic RNA oligos exhibit purity decreasing as a function of length, because the efficiency of the total synthesis is the numerical product of the individual step efficiencies, typically below 98%. Analytical methods for RNAs up to the 60 nucleotides (nt) have been reported, but they fall short for purity evaluation of 100nt long, used as single guide RNA (sgRNA) in CRISPR technology, and promoted as pharmaceuticals. In an attempt to exploit a single HPLC method and obtain both identity as we  ...[more]

Similar Datasets

| S-EPMC3668317 | biostudies-literature
| S-EPMC4440996 | biostudies-literature
| S-EPMC6227378 | biostudies-literature
| S-EPMC8822704 | biostudies-literature
| S-EPMC6393488 | biostudies-literature
| S-EPMC3203612 | biostudies-literature
| S-EPMC5372765 | biostudies-literature
| S-EPMC1143663 | biostudies-literature
| S-EPMC9855121 | biostudies-literature
| S-EPMC3209148 | biostudies-literature